The University of Oxford is part of a £15.9 million UK-wide programme to develop human tumour tissue models, improving cancer research, accelerating drug discovery and reducing reliance on animal testing.
Lord Victor Adebowale, chair and co-founder of Visionable, discusses why getting technology design right could be key to avoiding health inequity, especially during the COVID-19 crisis.
Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.
Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.
Genevieve Leveille, CEO of UK firm 08 Group and Co-Chair of the TechUK DLT Working Group, collaborates with digital health tech companies to deliver verified-safe China-sourced Covid-19 test kits at scale.
Director of Product Management at Bioquell, Guy Turner, explains how RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, thus providing a 6-log sporicidal kill and eliminating all traces of COVID-19.
Senior Accessibility Analyst at Digital Analyst Centre Mike Taylor discusses maximising technology to be both usable and accessible, and how to make it work for everyone.
In response to the COVID-19 health crisis, Rajant Corporation, has capitalised on its in-house manufacturing and provided essential protective free-of-charge face masks to aid the valiant efforts of healthcare workers.
Carlos Pinheiro, Principal Data Scientist, SAS, explores at mobility tracing as a more effective and safer alternative to contact tracing, one which would allow for lockdown measures to be eased more gradually.
Prof D. Chen-Yi Lee from the Department of Electronics Engineering at National Chiao Tung University in Taiwan, provides fascinating details about the project Toward Mobile Health-Care with Medical-IoT Devices.
Here, the International Agency for Research on Cancer and other experts provide an in-depth analysis of cancer, the second leading cause of death after cardiovascular diseases plus the role of technology and innovation in the field.
Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
John H. Breen, political scientist and advisor, explains the humanitarian necessity of a multilateral response to COVID-19 and offers policy suggestions.
Machine learning has already been widely accepted in the private sector, however, it is often feared in the public sector. Here, Simon Dennis, Director of AI & Analytics Innovation, SAS UK, explores the benefits of using machine learning in healthcare.
